Product Information
GENGRAF 25 MG CAPSULE is a brand (anda) product labeled by AbbVie Inc., priced at $1.8655 per EA under NDC 00074310832. Its NADAC has been published 216 times since Feb 10, 2016.
FDA first approved this application on May 12, 2000. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
AbbVie Inc.NDC
00074310832
Classification
Brand (ANDA)
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/2/2026
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA065003FDA Approved
5/12/2000
TE Code
AB1
On Market Since
11/1/2015
Pharmacological Classes
Price Statistics
The NADAC for GENGRAF 25 MG CAPSULE has been published 216 times since Feb 10, 2016, and over the history we have for it it has risen 59.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8655 per EA |
|---|---|
| All-time high | $1.8655 (Aug 19, 2026) |
| All-time low | $0.8235 (Oct 19, 2016) |
| 52-week high | $1.8655 |
| 52-week low | $1.7766 |
| Median price | $1.6895 |
| Average price | $1.4652 |
| Largest weekly change | +104.6% (Apr 17, 2024) |
| Weeks tracked | 216 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GENGRAF 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GENGRAF 25 MG CAPSULE, manufactured by AbbVie Inc., is $1.8655 per EA (NDC 00074310832), effective Aug 19, 2026.
How has the price of GENGRAF 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GENGRAF 25 MG CAPSULE has risen 59.8%. It has been tracked across 216 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for GENGRAF 25 MG CAPSULE?
Since Feb 10, 2016, the NADAC for GENGRAF 25 MG CAPSULE has ranged from a low of $0.8235 (Oct 19, 2016) to a high of $1.8655 (Aug 19, 2026), with a median of $1.6895 per EA.
Are there cheaper alternatives to GENGRAF 25 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOSPORINE MODIFIED 25 MG, is $0.3174 per EA — about 83% below GENGRAF 25 MG CAPSULE.
Who manufactures GENGRAF 25 MG CAPSULE?
GENGRAF 25 MG CAPSULE (NDC 00074310832) is labeled by AbbVie Inc., and CMS classifies it as a brand (anda) product.